TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
2 hedge funds and large institutions have $2.39M invested in TrovaGene, Inc. Warrant in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
22% more capital invested
Capital invested by funds: $1.95M → $2.39M (+$436K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.81K |
| 2 |
Millennium Management
New York
|
-$2.15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $2.39M | -$2.15K | -505 | -0.1% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1K | -$3.81K | -895 | -82% |
|
TROVW Hedge Fund Activity: Q1 2014 in Review
2 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q1 2014, worth a combined $2.39M — up 22% from $1.95M a quarter earlier.
Fund positioning in TROVW was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Tower Research Capital (TRC), cutting an estimated $3.81K.
- 2 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $2.39M of TrovaGene, Inc. Warrant stock for Q1 2014, up 22% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q1 2014 and 0 closed out.
- The largest TrovaGene, Inc. Warrant seller in Q1 2014 was Tower Research Capital (TRC), an estimated $3.81K sold.
Based on aggregated 13F filings for Q1 2014.